Recent advances toward defining the benefits and risks of erythrocyte transfusions in neonates

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 98, Issue 4, 2013, Pages

  Christensen, Robert D ^a   Ilstrup, Sarah ^b  

^a Intermountain Healthcare   (United States)

^b Intermountain Healthcare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTIFICIAL VENTILATION; BACTERIAL TRANSMISSION; BLOOD CELL COUNT; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION REACTION; CLINICAL PRACTICE; DIASTOLIC BLOOD PRESSURE; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED PRACTICE; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INTRAUTERINE BLOOD TRANSFUSION; LEUKOCYTE DIFFERENTIAL COUNT; LUNG DISEASE; MEAN ARTERIAL PRESSURE; NEAR INFRARED SPECTROSCOPY; NEWBORN INTENSIVE CARE; NEWBORN MONITORING; NEWBORN PERIOD; OXYGEN SATURATION; OXYGEN TENSION; OXYGEN TRANSPORT; PIROPLASMOSIS; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; RISK BENEFIT ANALYSIS; SPLANCHNIC BLOOD FLOW; STEM CELL TRANSPLANTATION; TACHYCARDIA; THROMBOCYTE COUNT; TISSUE OXYGENATION; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TRANSFUSION RELATED ACUTE LUNG INJURY; UMBILICAL CORD; UMBILICAL CORD BLOOD; VERY LOW BIRTH WEIGHT; WEST NILE FLAVIVIRUS;

DECISION MAKING; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84879507228     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2011-301265     Document Type: Review

References (109)

1. Strauss RG. 2008 Emily Cooley Memorial Lecture: lessons learned from pediatric transfusion medicine clinical trials. a little child shall lead them. Transfusion 2009;49:1996-2004.
2. Kirpalani H, Whyte R. Truths, associations, and hypotheses. J Pediatr 2011;159:359-61.
3. New HV, Stanworth SJ, Engelfriet CP, et al. Neonatal transfusions. Vox Sang 2009;96:62-85.
4. Christensen RD. Identifying neonates likely to benefit from a red blood cell transfusion. Transfusion 2012;52:217-18.
5. van Hoften JC, Verhagen EA, Keating P, et al. Cerebral tissue oxygen saturation and extraction in preterm infants before and after blood transfusion. Arch Dis Child Fetal Neonatal Ed 2010;95:F352-8.
6. Dani C, Pratesi S, Fontanelli G, et al. Blood transfusions increase cerebral, splanchnic, and renal oxygenation in anemic preterm infants. Transfusion 2010;50:1220-6.
7. Bailey SM, Hendricks-Muñoz KD, Wells JT, et al. Packed red blood cell transfusion increases regional cerebral and splanchnic tissue oxygen saturation in anemic symptomatic preterm infants. Am J Perinatol 2010;27:445-53.
8. Bailey SM, Hendricks-Muñoz KD, Mally P. Splanchnic-cerebral oxygenation ratio as a marker of preterm infant blood transfusion needs. Transfusion 2012;52:252-60.
9. Kuo JA, Maher KO, Kirshbom PM, et al. Red blood cell transfusion for infants with single-ventricle physiology. Pediatr Cardiol 2011;32:461-8.
10. Vamvakas EC. Allergic and anaphylactic reactions. In: Popovsky MA, ed. Transfusion Reactions. Third Edition. Bethesda (MD): American Association of Blood Banks 2007:105-56.
11. Gilstead CW. Anaphylactic transfusion reactions. Curr Opin Hematol 2003;10:419-23.
12. Heddle NM. Febrile nonhemolytic transfusion reactions. In: Popovsky MA, ed. Transfusion Reactions. Third Edition. Bethesda (MD): American Association of Blood Banks 2007:57-103.
13. Brubaker DB. Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions. Transfusion 1990;30:733-7. (Pubitemid 20361792)
14. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8. (Pubitemid 24276861)
15. Kopko PM, Popovsky MA. Transfusion-related acute lung injury. In: Popovsky MA, ed. Third Edition. Bethesda (MD): American Association of Blood Banks 2007:207-28.
16. FDA. Fatalities reported to FDA following blood collection and Transfusion: Annual summary for fiscal year 2010. Rockville, Maryland, 20 May 2011.
17. Arnold DM, Hume HA. Hypotensive transfusion reactions. In: Popovsky MA, ed. Transfusion Reactions. Third Edition. Bethesda (MD): American Association of Blood Banks 2007:251-73.
18. Davenport RD. Hemolytic transfusion reactions. In: Popovsky MA, ed. Transfusion Reactions. Third Edition. Bethesda (MD): American Association of Blood Banks 2007:1-55.
19. Alyea EP, Anderson KC. Transfusion-associated Graft-vs-host disease. In: Popovsky MA, ed. Transfusion Reactions. Third Edition. Bethesda (MD): American Association of Blood Banks 2007:229-49.
20. McFarland JG. Posttransfusion purpura. In: Popovsky MA, ed. Transfusion Reactions. Third Edition. Bethesda (MD): American Association of Blood Banks 2007:275-99.
21. Eder AF, Kennedy JM, Dy BA, et al.; American Red Cross Regional Blood Centers. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion 2009;49:1554-63.
22. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001;41:1493-9. (Pubitemid 34072672)
23. Eder AF, Goldman M. How do I investigate septic transfusion reactions and blood donors with culture-positive platelet donations? Transfusion 2011;51:1662-8.
24. Ramirez-Arcos S, Goldman M, Blajchman MA. Bacterial contamination. In: Popovsky MA, ed. Transfusion Reactions. Third Edition. Bethesda (MD): American Association of Blood Banks 2007:163-206.
25. Zou S, Stramer SL, Notari EP, et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009;49:1609-20.
26. Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010;50:1495-504.
27. Montgomery SP, Brown JA, Kuehnert M, et al.; 2003 West Nile Virus Transfusion-Associated Transmission Investigation Team. Transfusion-associated transmission of West Nile virus, United States 2003 through 2005. Transfusion 2006;46:2038-46. (Pubitemid 44813720)
28. Chohan G, Llewelyn C, Mackenzie J, et al. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause? Transfusion 2010;50:1003-6.
29. Puopolo M, Ladogana A, Vetrugno V, et al. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion 2011;51:1556-66.
30. Tonnetti L, Eder AF, Dy B, et al. Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 2009;49:2557-63.
31. Ibhanesebhor SE, Otobo ES, Ladipo OA. Prevalence of malaria parasitaemia in transfused donor blood in Benin City, Nigeria. Ann Trop Paediatr 1996;16:93-5. (Pubitemid 26164021)
32. Sanchez R, Toy P. Transfusion related acute lung injury: a pediatric perspective. Pediatr Blood Cancer 2005;45:248-55. (Pubitemid 41077157)
33. Gupta S, Som T, Iyer L, et al. Transfusion Related Acute Lung Injury in a Neonate. Indian J Pediatr 2012;79:1363-5.
34. Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 2010;67:1-8.
35. Bednarek FJ, Weisberger S, Richardson DK, et al. Variations in blood transfusions among newborn intensive care units. SNAP II Study Group. J Pediatr 1998;133:601-7. (Pubitemid 28521206)
36. Baer VL, Lambert DK, Henry E, et al. Among very-low-birth-weight neonates is red blood cell transfusion an independent risk factor for subsequently developing a severe intraventricular hemorrhage? Transfusion 2011;51:1170-8.
37. Baer VL, Lambert DK, Henry E, et al. Red blood cell transfusion of preterm neonates with a Grade 1 intraventricular hemorrhage is associated with extension to a Grade 3 or 4 hemorrhage. Transfusion 2011;51:1933-9.
38. Christensen RD. Associations between "early" RBC transfusion and severe IVH, and between "late" RBC transfusion and NEC. Semin Perinatol 2012;36:283-9.
39. McGrady GA, Rettig PJ, Istre GR, et al. An outbreak of necrotizing enterocolitis. Association with transfusions of packed red blood cells. Am J Epidemiol 1987;126:1165-72. (Pubitemid 18017801)
40. Mally P, Golombek SG, Mishra R, et al. Association of necrotizing enterocolitis with elective packed red blood cell transfusions in stable, growing, premature neonates. Am J Perinatol 2006;23:451-8. (Pubitemid 46535109)
41. Agwu JC, Narchi H. In a preterm infant, does blood transfusion increase the risk of necrotizing enterocolitis? Arch Dis Child 2005;90:102-3. (Pubitemid 40052269)
42. Christensen RD, Wiedmeier SE, Baer VL, et al. Antecedents of Bell stage III necrotizing enterocolitis. J Perinatol 2010;30:54-7.
43. Christensen RD, Lambert DK, Henry E, et al. Is "transfusion- associated necrotizing enterocolitis" an authentic pathogenic entity? Transfusion 2010;50:1106-12.
44. Josephson CD, Wesolowski A, Bao G, et al. Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants? J Pediatr 2010;157:972-8.e1-3.
45. Blau J, Calo JM, Dozor D, et al. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr 2011;158:403-9.
46. dos Santos AM, Guinsburg R, de Almeida MF, et al. Brazilian Network on Neonatal Research. Red blood cell transfusions are independently associated with intra-hospital mortality in very low birth weight preterm infants. J Pediatr 2011;159:371-6.e1-3.
47. Singh R, Visintainer PF, Frantz ID 3rd, et al. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J Perinatol 2011;31:176-82.
48. Paul DA, Mackley A, Novitsky A, et al. Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants. Pediatrics 2011;127:635-41.
49. El-Dib M, Narang S, Lee E, et al. Red blood cell transfusion, feeding and necrotizing enterocolitis in preterm infants. J Perinatol 2011;31:183-7.
50. Christensen RD, Gordon PV, Besner GE. Can we cut the incidence of necrotizing enterocolitis in half-today? Fetal Pediatr Pathol 2010;29:185-98.
51. Bifano EM, Curran TR. Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects. Clin Perinatol 1995;22:657-69.
52. Baer VL, Lambert DK, Henry E, et al. Do platelet transfusions in the NICU adversely affect survival? Analysis of 1600 thrombocytopenic neonates in a multihospital healthcare system. J Perinatol 2007;27:790-6. (Pubitemid 350176961)
53. Baer VL, Henry E, Lambert DK, et al. Implementing a program to improve compliance with neonatal intensive care unit transfusion guidelines was accompanied by a reduction in transfusion rate: a pre-post analysis within a multihospital health care system. Transfusion 2011;51:264-9.
54. Christensen RD, Henry E, Ilstrup S, et al. A high rate of compliance with neonatal intensive care unit transfusion guidelines persists even after a program to improve transfusion guideline compliance ended. Transfusion 2011;51:2519-20.
55. Ohls RK, Ehrenkranz RA, Das A, et al.; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 2004;114:1287-91. (Pubitemid 41647690)
56. Ohls RK, Dai A. Long-acting erythropoietin: clinical studies and potential uses in neonates. Clin Perinatol 2004;31:77-89. (Pubitemid 38748593)
57. Warwood TL, Ohls RK, Wiedmeier SE, et al. Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol 2005;25:725-30. (Pubitemid 41655648)
58. Warwood TL, Ohls RK, Lambert DK, et al. Urinary excretion of darbepoetin after intravenous vs subcutaneous administration to preterm neonates. J Perinatol 2006;26:636-9. (Pubitemid 44489569)
59. Warwood TL, Ohls RK, Lambert DK, et al. Intravenous administration of darbepoetin to NICU patients. J Perinatol 2006;26:296-300.
60. Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;3:CD004863.
61. Frey B. Transfusion in premature infants impairs production and/or release of red blood cells, white blood cells and platelets. J Paediatr Child Health 2002;38:265-7. (Pubitemid 34592182)
62. McCoy TE, Conrad AL, Richman LC, et al. Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol 2011;17:347-67.
63. Nopoulos PC, Conrad AL, Bell EF, et al. Long-term outcome of brain structure in premature infants: effects of liberal vs restricted red blood cell transfusions. Arch Pediatr Adolesc Med 2011;165:443-50.
64. Aher S, Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;3:CD004868.
65. Warwood TL, Lambert DK, Henry E, et al. Very low birth weight infants qualifying for a 'late' erythrocyte transfusion: does giving darbepoetin along with the transfusion counteract the transfusion' s erythropoietic suppression? J Perinatol 2011;31(Suppl 1):S17-21.
66. Slusarski JD, McPherson RJ, Wallace GN, et al. High-dose erythropoietin does not exacerbate retinopathy of prematurity in rats. Pediatr Res 2009;66:625-30.
67. Juul SE, McPherson RJ, Bauer LA, et al. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 2008;122:383-91.
68. McPherson RJ, Juul SE. Recent trends in erythropoietin-mediated neuroprotection. Int J Dev Neurosci 2008;26:103-11. (Pubitemid 351192267)
69. McPherson RJ, Juul SE. Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr 2010;22:139-45.
70. Bierer R, Peceny MC, Hartenberger CH, et al. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006;118:e635-40. (Pubitemid 46089988)
71. Bierer R, Roohi M, Peceny C, et al. Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery. J Pediatr Surg 2009;44:1540-5.
72. Bishara N, Ohls RK. Current controversies in the management of the anemia of prematurity. Semin Perinatol 2009;33:29-34.
73. Ohls RK, Roohi M, Peceny HM, et al. A randomized, masked study of weekly erythropoietin dosing in preterm infants. J Pediatr 2012;160:790-5.e1.
74. Mercer JS, Vohr BR, McGrath MM, et al. Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics 2006;117:1235-42. (Pubitemid 46071517)
75. Rabe H, Wacker A, Hülskamp G, et al. A randomised controlled trial of delayed cord clamping in very low birth weight preterm infants. Eur J Pediatr 2000;159:775-7.
76. Oh W, Fanaroff AA, Carlo WA, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Effects of delayed cord clamping in very-low-birth-weight infants. J Perinatol 2011;31(Suppl 1):S68-71.
77. Mercer JS, Vohr BR, Erickson-Owens DA, et al. Seven-month developmental outcomes of very low birth weight infants enrolled in a randomized controlled trial of delayed versus immediate cord clamping. J Perinatol 2010;30:11-16.
78. Rabe H, Reynolds G, Diaz-Rossello J. A systematic review and meta-analysis of a brief delay in clamping the umbilical cord of preterm infants. Neonatology 2008;93:138-44. (Pubitemid 351225344)
79. Rabe H, Reynolds G, Diaz-Rossello J. Early versus delayed umbilical cord clamping in preterm infants. Cochrane Database Syst Rev 2004;4:CD003248.
80. Bell EF. Increasing the placental transfusion for preterm infants. Obstet Gynecol 2011;117:203-4.
81. Cerdanis C. Early versus delayed umbilical cord clamping in preterm infants. RHL the WHO Reproductive Health Library. http://apps.who.int/rhl/ pregnancy-childbirth/childbirth/3rd-stage/jccom/en/index.html (accessed 30 May 2012).
82. Strauss RG, Mock DM, Johnson KJ, et al. A randomized clinical trial comparing immediate versus delayed clamping of the umbilical cord in preterm infants: short-term clinical and laboratory endpoints. Transfusion 2008;48:658-65. (Pubitemid 351430338)
83. Hosono S, Mugishima H, Fujita H, et al. Umbilical cord milking reduces the need for red cell transfusions and improves neonatal adaptation in infants born at less than 29 weeks' gestation: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2008;93:F14-9.
84. Hosono S, Mugishima H, Kitamura T, et al. Effect of hemoglobin on transfusion and neonatal adaptation in extremely low-birthweight infants. Pediatr Int 2008;50:306-11. (Pubitemid 351781506)
85. Rabe H, Jewison A, Alvarez RF, et al.; Brighton Perinatal Study Group. Milking compared with delayed cord clamping to increase placental transfusion in preterm neonates: a randomized controlled trial. Obstet Gynecol 2011;117:205-11.
86. Connell TG, Rele M, Cowley D, et al. How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 2007;119:891-6. (Pubitemid 46715658)
87. Carroll PD, Nankervis CA, Iams J, et al. Umbilical cord blood as a replacement source for admission complete blood count in premature infants. J Perinatol 2012;32:97-102.
88. Christensen RD, Lambert DK, Baer VL, et al. Postponing or eliminating red blood cell transfusions of very low birth weight neonates by obtaining all baseline laboratory blood tests from otherwise discarded fetal blood in the placenta. Transfusion 2011;51:253-8.
89. Alex CP, Manto JC, Garland JS. Clinical utility of a bedside blood analyzer for measuring blood chemistry values in neonates. J Perinatol 1998;18:45-8. (Pubitemid 128454197)
90. Billman GF, Hughes AB, Dudell GG, et al. Clinical performance of an in-line, ex vivo point-of-care monitor: a multicenter study. Clin Chem 2002;48:2030-43. (Pubitemid 35222762)
91. Madan A, Kumar R, Adams MM, et al. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J Perinatol 2005;25:21-5. (Pubitemid 40207649)
92. Mahieu L, Marien A, De Dooy J, et al. Implementation of a multi-parameter Point-of-Care-blood test analyzer reduces central laboratory testing and need for blood transfusions in very low birth weight infants. Clin Chim Acta 2012;413:325-30.
93. Paxon CL. Collection and use of autologous fetal blood. Am J Obstetr Gynecol 1979;134:708-10.
94. Golden SM, O'Brien WF, Lissner C, et al. Hematologic and bacteriologic assessment of autologous cord blood for neonatal transfusions. J Pediatr 1980;97:810-12. (Pubitemid 11216855)
95. Golden SM, Petit N, Mapes T, et al. Bacteriologic assessment of autologous cord blood for neonatal transfusion. Am J Obstet Gynecol 1984;149:907-8. (Pubitemid 14057218)
96. Rao M, Ahrlund-Richter L, Kaufman DS. Concise review: Cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities. Stem Cells 2012;30:55-60.
97. Strauss RG. Autologous transfusions for neonates using placental blood. A cautionary note. Am J Dis Child 1992;146:21-2.
98. Brune T, Garritsen H, Witteler R, et al. Autologous placental blood transfusion for the therapy of anaemic neonates. Biol Neonate 2002;81:236-43. (Pubitemid 34507591)
99. Khodabux CM, von Lindern JS, van Hilten JA, et al. A clinical study on the feasibility of autologous cord blood transfusion for anemia of prematurity. Transfusion 2008;48:1634-43.
100. Jansen M, Brand A, von Lindern JS, et al. Potential use of autologous umbilical cord blood red blood cells for early transfusion needs of premature infants. Transfusion 2006;46:1049-56. (Pubitemid 43800925)
101. Taguchi T, Suita S, Nakamura M, et al. The efficacy of autologous cord-blood transfusions in neonatal surgical patients. J Pediatr Surg 2003;38:604-7. (Pubitemid 36417803)
102. Eichler H, Schaible T, Richter E, et al. Cord blood as a source of autologous RBCs for transfusion to preterm infants. Transfusion 2000;40:1111-17.
103. Khodabux CM, Brand A. The use of cord blood for transfusion purposes: current status. Vox Sang 2009;97:281-93.
104. Strauss RG, Widness JA. Is there a role for autologous/placental red blood cell transfusions in the anemia of prematurity? Transfus Med Rev 2010;24:125-9.
105. Khodabux CM, van Beckhoven JM, Scharenberg JG, et al. Processing cord blood from premature infants into autologous red-blood-cell products for transfusion. Vox Sang 2011;100:367-73.
106. Strauss RG, Widness JA. Autologous or allogeneic: cord blood red blood cells still are investigational. Transfus Med Rev 2012;26:91-2.
107. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005;105:2266-73. (Pubitemid 40387018)
108. Narick C, Triulzi DJ, Yazer MH. Transfusion-associated circulatory overload after plasma transfusion. Transfusion 2012;52:160-5.
109. Kasat K, Hendricks-Muñoz KD, Mally PV. Neonatal red blood cell transfusions: searching for better guidelines. Blood Transfus 2011;9:86-94.